Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 401: 84-95, 2019 03 01.
Article in English | MEDLINE | ID: mdl-30668975

ABSTRACT

The endocannabinoid system (ECS) regulates several physiological processes in the Central Nervous System, including the modulation of neuronal excitability via activation of cannabinoid receptors (CBr). Both glutaric acid (GA) and quinolinic acid (QUIN) are endogenous metabolites that, under pathological conditions, recruit common toxic mechanisms. A synergistic effect between them has already been demonstrated, supporting potential implications for glutaric acidemia type I (GA I). Here we investigated the possible involvement of a cannabinoid component in the toxic model exerted by QUIN + GA in rat cortical slices and primary neuronal cell cultures. The effects of the CB1 receptor agonist anandamide (AEA), and the fatty acid amide hydrolase inhibitor URB597, were tested on cell viability in cortical brain slices and primary neuronal cultures exposed to QUIN, GA, or QUIN + GA. As a pre-treatment to the QUIN + GA condition, AEA prevented the loss of cell viability in both preparations. URB597 only protected in a moderate manner the cultured neuronal cells against the QUIN + GA-induced damage. The use of the CB1 receptor reverse agonist AM251 in both biological preparations prevented partially the protective effects exerted by AEA, thus suggesting a partial role of CB1 receptors in this toxic model. AEA also prevented the cell damage and apoptotic death induced by the synergic model in cell cultures. Altogether, these findings demonstrate a modulatory role of the ECS on the synergic toxic actions exerted by QUIN + GA, thus providing key information for the understanding of the pathophysiological events occurring in GA I.


Subject(s)
Arachidonic Acids/pharmacology , Cerebral Cortex/drug effects , Endocannabinoids/pharmacology , Glutarates/toxicity , Neurons/drug effects , Polyunsaturated Alkamides/pharmacology , Quinolinic Acid/toxicity , Animals , Benzamides/pharmacology , Cannabinoid Receptor Agonists/pharmacology , Carbamates/pharmacology , Cell Survival/drug effects , Cells, Cultured , Drug Synergism , Endocannabinoids/metabolism , Female , Male , Neurons/metabolism , Piperidines/pharmacology , Pregnancy , Pyrazoles/pharmacology , Rats , Rats, Inbred WF , Receptors, Cannabinoid/metabolism
2.
Neurotox Res ; 34(3): 640-648, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29949107

ABSTRACT

Molecules exhibiting antioxidant, neuroprotective, and regulatory properties inherent to natural products consumed by humans are gaining attention in biomedical research. Ferulic acid (FA) is a phenolic compound possessing antioxidant and cytoprotective properties. It is found in several vegetables, including sugarcane, where it serves as the main antioxidant component. Here, we compared the antioxidant and cytoprotective effects of FA with those of the total sugarcane aqueous extract (SCAE). Specifically, we assessed biochemical markers of cell dysfunction in rat cortical brain slices and markers of physiological stress in Caenorhabditis elegans upon exposure to toxins evoking different mechanisms of neurotoxicity, including direct oxidative stress and/or excitotoxicity. In rat cortical slices, FA (250 and 500 µM), but not SCAE (~ 270 µM of total polyphenols), prevented the loss of reductive capacity induced by the excitotoxin quinolinic acid (QUIN, 100 µM), the pro-oxidant agent ferrous sulfate (FeSO4, 25 µM), and the dopaminergic pro-oxidant 6-hydroxydopamine (6-OHDA, 100 µM). In wild-type (N2) C. elegans, FA (38 mM) exerted protective effects on decreased survival induced by FeSO4 (15 mM) and 6-OHDA (25 mM), and the motor alterations induced by QUIN (100 mM), FeSO4, and 6-OHDA. In contrast, SCAE (~ 13.5 mM of total polyphenols) evoked protective effects on the decreased survival induced by the three toxic agents, the motor alterations induced by FeSO4, and the reproductive deficit induced by FeSO4. In addition, FA was unable to reverse the decreased survival induced by all these toxins in the skn-1-/- strain (VC1772), which lacks the homolog of mammalian Nrf2, a master antioxidant gene. Altogether, our results suggest that (1) both FA and SCAE afford protection against toxic conditions, (2) not all the effects inherent to SCAE are due to FA, and (3) FA requires the skn-1 pathway to exert its protective effects in C. elegans.


Subject(s)
Coumaric Acids/therapeutic use , Neurotoxicity Syndromes/drug therapy , Plant Extracts/therapeutic use , Saccharum/chemistry , Analysis of Variance , Animals , Animals, Genetically Modified , Birth Rate , Caenorhabditis elegans , Caenorhabditis elegans Proteins/genetics , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Disease Models, Animal , Ferrous Compounds/toxicity , In Vitro Techniques , Iron/metabolism , Locomotion/drug effects , Male , Neurotoxicity Syndromes/etiology , Neurotoxicity Syndromes/physiopathology , Oxidopamine/toxicity , Plant Extracts/chemistry , Quinolinic Acid/toxicity , Rats , Rats, Wistar
3.
Neurotox Res ; 33(2): 259-267, 2018 02.
Article in English | MEDLINE | ID: mdl-28822104

ABSTRACT

The tryptophan metabolite, quinolinic acid (QUIN), and the mitochondrial toxin 3-nitropropionic acid (3-NP) are two important tools for toxicological research commonly used in neurotoxic models of excitotoxicity, oxidative stress, energy depletion, and neuronal cell death in mammals. However, their toxic properties have yet to be explored in the nematode Caenorhabditis elegans (C. elegans) for the establishment of novel, simpler, complementary, alternative, and predictive neurotoxic model of mammalian neurotoxicity. In this work, the effects of QUIN (1-100 mM) and 3-NP (1-10 mM) were evaluated on various physiological parameters (survival, locomotion, and longevity) in a wild-type (WT) strand of C. elegans (N2). Their effects were also tested in the VC1772 strain (knock out for the antioxidant SKN-1 pathway) and the VP596 strain (worms with a reporter gene for glutathione S-transferase (GST) transcription) in order to establish the role of the SKN-1 pathway in the mode of action of QUIN and 3-NP. In N2, the higher doses of both toxins decreased survival, though only QUIN altered motor activity. Both toxins also reduced longevity in the VC1772 strain (as compared to N2 strain) and augmented GST transcription in the VP596 strain at the highest doses. The changes induced by both toxins require high doses, and therefore appear moderate when compared with other toxic agents. Nevertheless, the alterations produced by QUIN and 3-NP in C. elegans are relevant to mammalian neurotoxicity as they provide novel mechanistic approaches to the assessment of neurotoxic events comprising oxidative stress and excitotoxicity, in the nematode model.


Subject(s)
Antihypertensive Agents/toxicity , Caenorhabditis elegans Proteins/drug effects , DNA-Binding Proteins/drug effects , Nitro Compounds/toxicity , Propionates/toxicity , Quinolinic Acid/toxicity , Transcription Factors/drug effects , Animals , Caenorhabditis elegans , Caenorhabditis elegans Proteins/metabolism , Corpus Striatum/drug effects , Disease Models, Animal , Mitochondria/drug effects , Neurotoxicity Syndromes/metabolism , Oxidative Stress/drug effects , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...